Opening China Offices Brings FDA Early Test On Bridging Globalization Gaps
This article was originally published in The Tan Sheet
FDA's opening of offices in China will be an early test of how the agency handles the challenges of globalization, not only in working with foreign governments but also in restructuring itself to operate with worldwide footing
You may also be interested in...
FDA will shoot to double its inspections of foreign facilities in fiscal 2010 to more than 2,000
FDA wants risk-based draft guidances it published this year to increase industry accountability and free resources for high-risk inspections as the number of foreign-sourced drugs entering the U.S. exceeds the agency's inspection capabilities
FDA appoints global, IT heads: The agency has chosen Lou Valdez as associate commissioner for international programs and Lori Davis as chief information officer. Valdez will lead the agency's further international expansion, with office openings planned for India, Latin America and the Middle East, FDA says Jan. 12. Melinda Plaisier stepped down as associate commissioner for international programs in October to become director of the Central region office in FDA's Office of Regulatory Affairs (1"The Tan Sheet" Dec. 8, 2008, p. 8). Davis has been deputy CIO since November 2007 and will now drive FDA's multi-year information technology modernization program, which will improve import and food protection by enhancing system interoperability